New Mexico Administrative Code

A. Medical malpractice payments. Any health care entity or person failing to report malpractice payments required by this part shall be subject to a civil penalty not to exceed ten thousand dollars ($10,000). B. Actions adversely affecting clinical privileges. Any health care ent…

Any information or report submitted to the board under this part, or pursuant to 42 U.S.C. 11131-11152, as amended, shall be confidential and shall be disclosed only to the licensee or applicant, unless otherwise authorized or required by law.

A. In addition to the reporting requirements contained in Section 16.10.10.8 and 16.10.10.9 NMAC, a licensee or applicant shall report to the board any adverse action affecting the licensee or applicant taken by another licensing jurisdiction; a peer review body; a health care en…

A. Consistent with 16.10.8.9 NMAC (adopting the ethical standards of the American medical association), licensees and applicants having a good faith basis for believing that the public health and safety may be at risk must report impaired, incompetent, disruptive and unethical co…

A. All applicants and licensees have a duty to self-report to the board any mental illness, physical illness (including but not limited to deterioration through the aging process or loss of motor skill), or habitual use or abuse of drugs, as defined in the Controlled Substances A…

This part applies to all applicants and licensees under the jurisdiction of the Medical Practice Act, Sections 61-6-1 to -35 NMSA 1978, and entities falling within the scope of Section 61-6-16 NMSA 1978.

This part is adopted pursuant to Paragraph (21) of Subsection D of Sections 61-6-15 and 61-6-16 NMSA 1978, and in accordance with the Impaired Health Care Provider Act Sections 61-7-1 to 61-7-12 NMSA 1978.

This part is permanent.

The effective date of this part is September 17, 2018, unless a later date appears at the end of a section.

This part has three objectives. A. In accordance with Paragraph (21) of Subsection D of Section 61-6-15 NMSA 1978, this part defines the requirements for licensees and applicants to report to the board actions taken against them by other licensing jurisdictions, peer review bodie…

The following definitions apply to this section. All terms not defined have their general dictionary meaning. A. "Adverse action" means any discipline, sanction or other action, whether equitable, administrative, civil or criminal, affecting a licensee, applicant or other person …

A. Each person or entity, including an insurance company, which makes a payment under a policy of insurance, self-insurance or otherwise, in settlement of, or in whole or partial satisfaction of, a judgment in a malpractice action or claim must file a report with the board within…

A. All health care entities, licensees and applicants shall report any action adversely affecting the clinical privileges of the licensee or applicant within thirty days after the action is taken. B. Actions the health care entity must report include, but are not limited to: (1) …

New Mexico Medical Board, hereafter called the board.

A. Supervising physicians must provide direction to pharmacist clinicians to specify the pharmacotherapeutic services to be provided under the circumstances in each case. This may be done by written protocol or by oral consultation. It is the responsibility of the supervising phy…

The chair of the board shall appoint two (2) members of the board, or a member and an agent of the board to an oversight committee that shall also include two members appointed by the board of pharmacy. The oversight committee will make a report that may include non-binding recom…

A. Required documentation. Each applicant for a pharmacist clinician supervisor and alternate pharmacist clinician supervisor must submit the required fees as specified in 16.10.9.8 NMAC and the following documentation: (1) A completed signed application. (2) Copy of proof of cur…

This applies to physicians who supervise pharmacist clinicians.

These rules of practice and procedure govern the practice of medicine in New Mexico and are promulgated pursuant to and in accordance with the Medical Practice Act, sections 61-6-1 through 61-6-35 NMSA 1978, the Uniform Licensing Act, section 61-1-1 through 61-1-33 NMSA 1978, and…

Permanent

June 15, 1995, unless a later date is cited at the end of a section.

These rules and regulations are adopted to carry out the boards' responsibilities set forth in Sections 61-11B to 61-11B-3, NMSA 1978, the "Pharmacist Prescriptive Authority Act."

A. "Alternate supervising physician" means a physician who holds a current unrestricted license, is a cosignatory on the notification of supervision, and agrees to act as the supervising physician in the supervising physician's absence with no change to the scope of practice or p…

These rules and regulations are adopted to carry out the boards' responsibilities set forth in Sections 61-11B to 61-11B-3, NMSA 1978, the "Pharmacist Prescriptive Authority Act."

A physician shall only be approved as a pharmacist clinician supervisor after the pharmacist clinician registers with the board by submitting an application for authority to practice under the supervision of a licensed physician. The application shall include: A. the name, addres…

New Mexico Medical Board, hereafter called the board.

This part applies to physicians supervising physicians under Section 61-6-17(I) NMSA 1978.

These rules of practice and procedure govern the practice of medicine in New Mexico and are promulgated pursuant to and in accordance with the Medical Practice Act, Sections 61-6-1 through 61-6-35 NMSA 1978, the Uniform Licensing Act, Sections 61-1-1 through 61-1-33 NMSA 1978, an…

Permanent

March 17, 1998, unless a later date is cited at the end of a section.

This part establishes procedures for New Mexico licensed physicians to delegate responsibilities to physicians not licensed in New Mexico, pursuant to Section 61-6-17(I) NMSA 1978, as amended in 1997.

A. "Non-licensed physician" means a medical doctor licensed to practice medicine in a jurisdiction other than New Mexico. B. "Board" means the New Mexico medical board. C. "Supervising physician" means a physician licensed in the state of New Mexico by the board who will function…

A. In order for a non-licensed physician who is practicing medicine in New Mexico under a New Mexico licensed physician's supervision, the non-licensed physician, pursuant to Section 61-6-17(I) NMSA 1978, as amended in 1997, shall have an unrestricted license to practice in some …

New Mexico Medical Board, hereafter called the board.

This part governs the delegated use of procedures and use of certain medical devices by medical assistants under the supervision of the physician.

These rules of practice and procedure govern the use of medical devices and procedures by unlicensed medical assistants under the supervision of a physician in New Mexico. These rules are promulgated pursuant to and in accordance with the Medical Practice Act, Sections 61-6-1 thr…

Permanent

April 18, 2002, unless a different date is cited at the end of a section.

This part establishes the procedures whereby physicians licensed in New Mexico may delegate responsibility for certain medical procedures generally considered to be the practice of medicine to medical assistants with appropriate training and supervision, pursuant to Section 61-6-…

A. "Supervising physician" means a physician licensed to practice in New Mexico who is responsible for the patient's care and will provide oversight and guidance of the medical assistant. B. "Medical assistant" means any individual who is not licensed as a healthcare practitioner…

Medical therapeutic or cosmetic devices penetrate and alter human tissue and can result in complications such as visual impairment, blindness, inflammation, burns, scarring, hypo-pigmentation and hyper-pigmentation. The use of medical therapeutic and cosmetic devices is the pract…

The injection of cosmetic or aesthetic substances is considered to be the practice of medicine and shall not be delegated to medical assistants.

New Mexico Medical Board, hereafter called the board.

Physicians, physician assistants or anesthesiologist assistants who have chronic pain and are being treated with opiates shall be evaluated by a pain clinic or, by a physician pain specialist, and must have a complete, independent neuropsychological evaluation, as well as clearan…

This section applies to all New Mexico medical board licensees who hold a federal drug enforcement administration registration and a New Mexico controlled substances registration. Pursuant to the Pain Relief Act, in order to ensure that all such health care practitioners safely p…

In addition to the notice of procedures set forth in the State Rules Act, Section 14-4-1 et seq NMSA 1978, the board shall separately notify the following persons of the Pain Relief Act and Part 14 of the New Mexico medical board rule, 16.10.14 NMAC; A. health care practitioners …

A. A health care provider who prescribes, distributes or dispenses an opioid analgesic for the first time to a patient shall advise the patient on the risks of overdose and inform the patient of the availability of an opioid antagonist. With respect to a patient to whom an opioid…

This part applies to all New Mexico medical board licensees who hold a federal drug enforcement administration registration.

These rules are promulgated pursuant to and in accordance with the Medical Practice Act, Sections 61-6-1 through 61-6-35 NMSA 1978 and the Pain Relief Act, Sections 24-2D-1 NMSA through 24-2D-6.

Permanent